In an effort to determine the inflammatory effectors which modulate CD248 expression, we treated two different models of MSCs (skin and synovial tissue) in vitro with a range of growth factors and cytokines that have been identified as perpetrators of the pathology of cancer and arthritis. Here, CD248 is linked to arthritic joint disease.